Meeting to be held on December 10 hosted by Oppenheimer.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics price target raised to $54 from $22 at Oppenheimer
- Capricor Therapeutics Announces $150 Million Public Offering
- Capricor Therapeutics 6M share Spot Secondary priced at $25.00
- Capricor TBA Spot Secondary; shares are being re-offered at $25.00
- Capricor Therapeutics announces common stock offering, no amount given